Difference between revisions of "Agomelatine-venlafaxine"

From Psychiatrienet
Jump to: navigation, search
Line 2: Line 2:
 
| from = agomelatine  
 
| from = agomelatine  
 
| to = venlafaxine  
 
| to = venlafaxine  
| stop =  
+
| stop = {{StopAgomelatine}}
* Agomelatine can be stopped abruptly for every dosage.
 
 
| start =  
 
| start =  
 
* No wash-out period is necessary.
 
* No wash-out period is necessary.
 
* The next day: {{startVenla}}
 
* The next day: {{startVenla}}
<ref name="agoswitch"> {{Pubmed|20196187|McAllister-Williams RH et al. The use of antidepressants in clinical practice: focus on agomelatine. Hum Psychopharmacol. 2010 Mar 1;25(2):95-102}}</ref>
 
 
}}
 
}}

Revision as of 14:06, 5 March 2010

Agomelatine
Type Antidepressant
Group other
links
ATC-code N06AX22
EMEA valdoxan
PubChem 82148
PubMed Agomelatine
Kompas (Dutch) Agomelatine
Wikipedia Agomelatine
Venlafaxine
Type Antidepressant
Group SNRI
links
Medscape Venlafaxine
PubChem 5656
PubMed Venlafaxine
Kompas (Dutch) Venlafaxine
Wikipedia Venlafaxine

Switch medication from agomelatine to venlafaxine.

Nietinrijdenbord.png Stop agomelatine
  • Day 1: Stop agomelatine.
  • Agomelatine can be stopped abruptly for every dosage.[1]
Eenrichtingbord.png Start venlafaxine
  • No wash-out period is necessary.
  • The next day: Start administration of venlafaxine in a normal dosage of 37,5 mg or 75 mg (slow release) /day.


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.